ArticleCancer communications (London, England)2022

Optimized therapeutic strategy for patients with refractory or relapsed acute myeloid leukemia: long-term clinical outcomes and health-related quality of life assessment.

Chen-Hua Yan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.